These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

183 related articles for article (PubMed ID: 3160046)

  • 21. Evidence for gene-environmental interactions in Utah families with hypertension, dyslipidaemia and early coronary heart disease.
    Williams RR; Hunt SC; Hopkins PN; Wu LL; Schumacher MC; Stults BM; Ball L; Ware J; Hasstedt SJ; Lalouel JM
    Clin Exp Pharmacol Physiol Suppl; 1992; 20():1-6. PubMed ID: 1446402
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [The genetic contribution to coronary disease. The genetic factors related to lipid metabolism].
    da Silva PM
    Rev Port Cardiol; 1999; 18(7-8):735-47. PubMed ID: 10466375
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Combined effects of apoE-CI-CII cluster and LDL-R gene polymorphisms on chromosome 19 and coronary artery disease risk.
    Wang C; Zhou X; Ye S; Han D; Tan X; Zheng F; Shi Q
    Int J Hyg Environ Health; 2006 May; 209(3):265-73. PubMed ID: 16459141
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Serum lipids in the GENECARD study of coronary artery disease identify quantitative trait loci and phenotypic subsets on chromosomes 3q and 5q.
    Shah SH; Kraus WE; Crossman DC; Granger CB; Haines JL; Jones CJ; Mooser V; Huang L; Haynes C; Dowdy E; Vega GL; Grundy SM; Vance JM; Hauser ER
    Ann Hum Genet; 2006 Nov; 70(Pt 6):738-48. PubMed ID: 17044848
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Context-dependent and invariant associations between APOE genotype and levels of lipoproteins and risk of ischemic heart disease: a review.
    Frikke-Schmidt R
    Scand J Clin Lab Invest Suppl; 2000; 233():3-25. PubMed ID: 11317940
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Lipoprotein(a)--atherogenic waste product of evolution?].
    Kronenberg F; Utermann G
    Wien Med Wochenschr; 1994; 144(12-13):324-30. PubMed ID: 8650938
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Genetic heterogeneity of apolipoprotein E and its influence on plasma lipid and lipoprotein levels.
    de Knijff P; van den Maagdenberg AM; Frants RR; Havekes LM
    Hum Mutat; 1994; 4(3):178-94. PubMed ID: 7833947
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Apolipoprotein E polymorphism in the early onset of coronary heart disease.
    Yang Z; Zhu T; Ma G; Yin H; Qian W; Zhang F; Cao K; Ma W
    Chin Med J (Engl); 2001 Sep; 114(9):983-5. PubMed ID: 11780396
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Linkage between the APOB gene and serum ApoB levels in a large pedigree from the Bogalusa Heart Study.
    Laing AE; Amos CI; DeMeester C; Diep A; Xia YR; Elston RC; Srinivasan SR; Berenson GS; Lusis AJ
    Genet Epidemiol; 1994; 11(1):29-40. PubMed ID: 7912214
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Effect of apolipoprotein E polymorphism and apolipoprotein A-1 gene promoter polymorphism on lipid parameters and premature coronary artery disease.
    Petrovic D; Zorc M; Peterlin B
    Folia Biol (Praha); 2000; 46(5):181-5. PubMed ID: 11055796
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Molecular genetics of heart diseases. A familial approach].
    Junien C
    Arch Mal Coeur Vaiss; 1991 Feb; 84(2):201-11. PubMed ID: 2021282
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Research using immunogenetic markers in the basic risk factors for ischemic heart disease in a family].
    Bubnov IuI
    Biull Vsesoiuznogo Kardiol Nauchn Tsentra AMN SSSR; 1987; 10(1):37-40. PubMed ID: 3475072
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Usefulness of genetic polymorphisms and conventional risk factors to predict coronary heart disease in patients with familial hypercholesterolemia.
    van der Net JB; Janssens AC; Defesche JC; Kastelein JJ; Sijbrands EJ; Steyerberg EW
    Am J Cardiol; 2009 Feb; 103(3):375-80. PubMed ID: 19166692
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The molecular genetic basis and diagnosis of familial hypercholesterolemia in Denmark.
    Jensen HK
    Dan Med Bull; 2002 Nov; 49(4):318-45. PubMed ID: 12553167
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Apolipoprotein E gene polymorphism and gender.
    Kolovou G; Damaskos D; Anagnostopoulou K; Cokkinos DV
    Ann Clin Lab Sci; 2009; 39(2):120-33. PubMed ID: 19429797
    [TBL] [Abstract][Full Text] [Related]  

  • 36. DNA, hyperlipidaemias and atherosclerosis.
    Kontula K; Aalto-Setälä K; Nikkilä E
    Ann Clin Res; 1986; 18(5-6):242-9. PubMed ID: 3551772
    [No Abstract]   [Full Text] [Related]  

  • 37. The child is father of the man.
    Glueck CJ
    Pediatrics; 1986 Aug; 78(2):364-8. PubMed ID: 3526271
    [No Abstract]   [Full Text] [Related]  

  • 38. Dyslipidaemia and coronary heart disease: nature vs nurture.
    Hegele RA
    Br J Hosp Med; 1995 Aug 16-Sep 5; 54(4):143-6. PubMed ID: 7582364
    [TBL] [Abstract][Full Text] [Related]  

  • 39. A comprehensive linkage analysis for myocardial infarction and its related risk factors.
    Broeckel U; Hengstenberg C; Mayer B; Holmer S; Martin LJ; Comuzzie AG; Blangero J; Nürnberg P; Reis A; Riegger GA; Jacob HJ; Schunkert H
    Nat Genet; 2002 Feb; 30(2):210-4. PubMed ID: 11818963
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Influence of polymorphisms for apolipoprotein B (ins/del, XbaI, EcoRI) and apolipoprotein E on serum lipids and apolipoproteins in a Javanese population.
    Gajra B; Candlish JK; Saha N; Heng CK; Soemantri AG; Tay JS
    Genet Epidemiol; 1994; 11(1):19-27. PubMed ID: 8013886
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.